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An efficient gene transfer into target tissues and cells is needed for safe and effective treatment of genetic diseases 
like cancer. In this paper, we describe the development of a transport system and show its ability for transporting 
plasmids. This non-viral peptide-based BioShuttle-mediated transfer system consists of a nuclear localization 
address sequence realizing the delivery of the plasmid phNIS-IRES-EGFP coding for two independent reporter 
genes into nuclei of HeLa cells. The quantification of the transfer efficiency was achieved by measurements of the 
sodium iodide symporter activity. EGFP gene expression was measured with Confocal Laser Scanning 
Microscopy and quantified with biostatistical methods by analysis of the frequency of the amplitude distribution 
in the CLSM images. The results demonstrate that the “BioShuttle”-Technology is an appropriate tool for an 
effective transfer of genetic material carried by a plasmid. 
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1.  Introduction 
‘Cancer’ and its initiation can be described as a 
‘genetic accident’. At present, more than 200 genes are 
known to play a role in the generation of cancer [1]. At 
least some of these genes are promising candidates for 
genetic interventions [2]. The treatment of genetic 
diseases (hereditary and metabolic diseases, cancer) 
means to introduce one or more therapeutic genes into 
the target cells, which are able to compensate a genetic 
malfunction [3]. In this context, genetic therapy 
approaches provide the potential to repair genetic 
diseases, but are limited by a poor efficiency and a lack 
of therapeutic safety of the commonly used delivery 
systems [4]. The most important steps for the efficient 
transport of therapeutic genetic material into the cell 
nucleus of the target cells are the rapid transport across 
the plasma membrane into the cytosol and the direct 
passage through the nuclear envelope into the nucleus. 
Numerous delivery systems have been developed to 
overcome these barriers, such as: viral vectors 
containing plasmids with genes of interest [5], physical 
methods such as ultrasound to facilitate the delivery of 
therapeutic genetic agents across cell membranes [6], 
and non-viral peptide-based carrier systems, based on 
lipids and/or cationic polymers which are taken up by 
cellular mechanisms in different cell lines as reviewed 
[7]. 
Until now, the transport of genetic material across 
the cell membrane into the cytoplasm has been 
addressed, but not it’s further delivery into the cell 
nucleus. Because only the DNA reaching the nucleus 
can be actively transcribed, our approach is to 
transport DNA through cell barriers into the nucleus 
using a Clamp-PNA-BioShuttle as carrier. It consists of 
modules for the transport across the cell membrane, a 
module for the cell nucleus transport and a 
hybridization-site including two identical chains of 
cysteine spacers connected to peptide nucleic acids 
acting as clutch for the phNIS-IRES-EGFP plasmid 
coding for two reporter genes. We show the GFP 
distribution and quantitation of reporter genes in cells 
after lipid-mediated transfection in comparison to cells 
treated with Clamp-PNA-BioShuttle-phNIS-IRES--
EGFP and outline the activity of the sodium iodide 
symporter (hNIS) [8]. 
2.  Material and Methods 
Cell culture 
The human cervix carcinoma cell line HeLa was 
obtained from the DKFZ-Tumorbank. Monolayer 
cultures of HeLa cells were cultured in RPMI 1640 
medium supplemented with 10% (vol/vol) FBS and 2 
mM  L-glutamine (GIBCO BRL) in a 5% CO2 
atmosphere at 37°C temperature to a density of near 1 Int. J. Med. Sci. 2007, 4 
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× 106 cells per ml. The medium was refreshed 24 hours 
before the DNA transfer procedures.  
Creation of the plasmid phNIS-IRES-EGFP with 
two reporter genes 
A bi-cistronic vector was built by a combination 
of two reporter genes. The pIRES2-EGFP vector (BD 
Bioscience, Clontech) was used as basic plasmid. The 
human Sodium-Iodide-Symporter gene (hNIS) 
(DKFZ-division of Nuclear Medicine) was inserted 
into the MCS of the pIRES2-EGFP plasmid. The 
resulting recombined vector was the 
phNIS-IRES-EGFP which possesses a common CMV 
promotor followed by the hNIS gene, the Internal 
Ribosome Entry Site (IRES) and the gene encoding the 
Enhanced Green Fluorescent Proteins (EGFP).  
Chemical synthesis of the Clamp-PNA-BioShuttle 
The complementary PNA-sequences for 
hybridization to the different ORI-target sequences of 
the phNIS-IRES-EGFP were identified. The syntheses 
of both - peptide modules and the PNA were carried 
out by Solid Phase Peptide Synthesis (SPPS) in a fully 
automated synthesizer Syro II (Multi SynTech, 
Germany). For PNA synthesis, we used 
fluorenylmethoxycarbonyl (Fmoc)-protected 
monomers with the exocyclic amino groups of A, G, 
and C bases blocked by a 
benzhydroxyl (Bhoc) group. 
Sequences of single modules 
as well as the complete 
modular construct were 
characterized with analytical 
HPLC (Shimadzu LC-10, 
Japan) and laser desorption 
mass spectrometry (Finnigan 
Vision 2000, England) 
showing over 90% purity of the products. Myristic acid 
was coupled with tetramethylfluoroformamidium--
hexafluorophosphate (TFFH) in dimethylformamide/ 
dichloromethane for one hour at the N terminus of 
PNA. Cysteine groups were attached via one of the 
COOH-terminal lysine residue of pAntp(43–58)–Cys 
and at the NH2-terminus of (NLS[SV40-T]). Molecules 
were oxidized in an aqueous solution of 2mg/ml in 
20% DMSO for about five hours. The oxidation 
progress was monitored by analytical C18 
reverse-phase HPLC. Peptide nucleic acids as well as 
the address peptide (NLS) carried one lysine-lysine 
spacer at the COOH terminus, which enabled linkage 
of peptide nucleic acids with identical sequence via a 
succinimidyl ester in a molar ratio of 1:1.  
Modules of the Clamp-PNA-BioShuttle 
The Clamp-PNA-BioShuttle consists of the 
following modules (figure 1): 
A. Transmembrane transport unit as mediator of 
the transport across outer membranes.  
B.  Mediator of the cellular compartment 
(nucleus) addressed transport. 
C.  Hybridization-site harbouring two identical 
PNA-sequences connected with lysine via a duplex 
glycine spacer. 
 
Figure 1  Chemical  structure 
of Clamp-PNA-BioShuttle 
phNIS-IRES-EGFP.  The 
transport molecule consists of: A. 
Amphiphilic transmembrane 
transport module responsible for 
the transport across outer cellular 
membranes into the cytoplasm. B. 
Address sequence peptide which 
potentiates the active transport of 
cargos into cell nuclei using 
RAN-mediated mechanisms.  C. 
Hybridization-site harbouring 
two identical PNA-sequences 
against ORI-sequences of the 
phNIS-IRES-EGFP, connected 
with lysine via a duplex glycine 
spacer.  Int. J. Med. Sci. 2007, 4 
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Hybridization of the phNIS-IRES-EGFP and the 
Clamp-BioShuttle transporter 
The hybridization of the Clamp-PNA-BioShuttle 
with the phNIS-IRES-EGFP was performed according 
to the procedure of R.J. Britten and D.E. Kohne [9]. 
Therefore plasmid DNA was dissolved in TRIS-HCl 
(0.05 M; pH  6.8) and the BioShuttle-PNA (1mg/ml) 
was added in a 1:1 ratio and heated in a water bath to 
56°C over 10 minutes. The careful tempering to room 
temperature allows a gentle annealing of the PNA to 
DNA. The strong affinity of PNA to DNA allows the 
hybridization reaction of the Clamp-BioShuttle with 
the  phNIS-IRES-EGFP liquid in reaction tubes. 
Subsequently the hybridized conjugate was directly 
applied to the cell culture without removing the 
medium. 
BioShuttle-mediated DNA transfer 
HeLa cervix carcinoma cells were incubated in 
6-well plates (Falcon) with the Clamp-PNA-BioShuttle 
over 60 minutes (final concentration was 20 nM) at 
37°C and 5% CO2 atmosphere. Figure 1 represents the 
modular structure of the 
Clamp-PNA-BioShuttle-phNIS-IRES-EGFP and the 
two sequence specific binding sites (called ORI and 
ORI 2). ORI 1 and ORI 2 represent sequences 
complementary to the DNA in the plasmid origin 
region as depicted in figure 1. The two (ORI 1 and ORI 
2) Clamp-PNA-BioShuttle-phNIS-IRES-EGFP 
complexes were dissolved in water to establish a stock 
solution (1mg/ml). In the following transfer 100 µl 
stock solution was diluted with 900 µl water. For gene 
transfer experiments we used 0.5 µl solution/ µg 
plasmid DNA.  
Lipid-mediated DNA transfection 
The preparation of the plasmid DNA was carried 
out according to the manufactures protocol 
(Macherey-Nagel, Germany). Before transfection 3 µg 
phNIS-IRES-EGFP and 7 µl LipofectAmin®2000TM 
(Invitrogen, Karlsbad) were incubated in 350 µl 
serum-free RPMI over 30 minutes.   
HeLa monolayer cells, 106 per ml, were 80-90% 
confluent after 24 hours. Cells were washed twofold 
with Hanks before application of the 700µl 
LipofectAmin®2000TM-phNIS-IRES-EGFP mix. HeLa 
cells were transfected and incubated at 37°C without 
addition of medium. After 1 hour we added the 
culture medium and investigated the cells at 24, 48, 
and 72 hours. 
Flow cytometry studies of cell mortality  
After hybridization of the phNIS-IRES-EGFP 
and the Clamp-PNA-BioShuttle transporter, the 
analysis was performed in a FACS Calibur flow 
cytometer (Becton Dickinson Cytometry Systems, San 
Jose, (CA) equipped with an argon laser (488nm) and a 
filter combination for propidium iodide. We used the 
forward scatter and side scatter and the relative 
fluorescence intensity of propidium iodide stained 
native cells on FL-2 channel in a logarithmic scale (Cell 
Quest, Becton Dickinson). Dead cells are positive for 
propidium iodide and stained red, living cells remain 
unstained. The positions in a logarithmic histogram 
are in the first two decades (102) for unstained cells, red 
stained dead cells are placed in the fourth decade (103). 
Iodide-125 uptake studies 
Incubation procedures and uptake kinetics 
studies with iodide-125 were carried out in accordance 
to the instructions published by Haberkorn et al. in 
2001 [10]. 
Confocal Laser Scanning Microscopy 
The intracellular distribution of the EGFP protein 
was compared after transfer of the 
Clamp-PNA-BioShuttle-phNIS-IRES-EGFP  and after 
transfection by LipofectAmin® into HeLa cells by a 
Zeiss confocal laser scanning microscope (LSM 
510-Meta). For excitation, we used the laser line at 488 
nm and the corresponding filter barrier for measuring 
the emission. Simultaneously with the fluorescence 
images, images in transmitted light in phase contrast 
or differential interference contrast (DIC) were taken 
also. 
As a control we used untreated cells as well as 
cells treated with the Clamp-PNA-BioShuttle without 
plasmid DNA and phNIS-IRES-EGFP without 
Clamp-PNA-BioShuttle. All measurements were 
carried out as triplicate. 
Parameters of the image acquisition were 
adapted to show the signal intensities in accordance 
with the visual microscopic image aspect. The numeric 
values of the frequencies of signal intensities were 
used for quantitative evaluation. 
Quantitative evaluation  
The counts (frequency) of signal intensities in the 
observed standard areas seem to follow an exponential 
law of the form y=eax+b. Therefore we took (natural) 
logarithms of these values and fitted a straight line by 
linear regression methods, providing us with the 
parameters a and b. 
We measured the intensity in the range from 1992 
to 4072 frequencies subdivided in intervals of length 16 
giving a total number of 130 intervals. Then we 
identified these intervals with their midpoints, e.g. 
2000, 2016 up to 4064. As raw data we measured the 
midpoints of the intervals and the sum of counts 
within these intervals. The total number of counts for 
47× were 134831 and for 48× 50509, respectively, which 
is sufficient for the quantification and statistical 
analysis.  
3.  Results 
The central question of this work was to find out 
whether functional genes (plasmid) can be efficiently 
transferred by the BioShuttle-transport system and 
whether they are transcribed and translated correctly. 
This should be achieved in two steps. (I) 
Measurement of DNA transfer into cells with help of 
the reporter gene EGFP. (II) Quantitation of the 
transferred DNA-function with help of the sodium 
iodide symporter (hNIS) system, based on the cellular Int. J. Med. Sci. 2007, 4 
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uptake of iodide-125 by the cells and by quantitation of 
the EGFP expression.  
The plasmid construct was not designed to create 
a fusion peptide. We used a bi-cistronic plasmid with a 
second internal ribosomal entry site (IRES) to create 
two independently translated proteins. The cellular 
iodide-125 uptake correlates with both the sodium 
iodide symporter (hNIS) expression and with the 
EGFP-expression. 
Display of the junction site  
In order to examine the hybridization of the 
Clamp-PNA-BioShuttle to phNIS-IRES-EGFP,  a gel 
electrophoresis was carried out (data not shown). As 
hybridization sites two different prokaryotic ‘origin of 
replication’ sequences (ORI) were investigated. The 
combined Clamp-PNA-BioShuttle together with the 
plasmid was digested with restriction enzymes.  
After digestion of the plasmid 
phNIS-IRES-EGFP with Aas I and Dra I the following 
fragments were expected (kb scale) 
1062--1707--1588--369--956--1117--19--653, which were 
arranged in the agarose gel: 
1707--1588--1117--1062--956--(369)--(19). The digest of 
the phNIS-IRES-EGFP is schematized in figure 2 and 
in table 1.  
 
Figure 2  Physical map of phNIS-IRES-EGFP. The inner circle of the map shows functional units. The outer circle represents 
the map units of the restriction sites. The bp positions represent the restrictions sites of the enzymes Aas 1 and Dra 1 respectively.  
 
Table 1  Schematic display of the Aas I and Dra I digestion of phNIS-IRES-EGFP. The table summarizes the size of the 
plasmid DNA fragments of the phNIS-IRES-EGFP and its transport form Clamp-PNA-BioShuttle-phNIS-IRES-EGFP after 
cleavage with restriction enzymes Aas I and Dra I.  





fragments after digestion with 





fragments after digestion with 
DraI and AasI  
1957    1957 = 1588 + 369  1957    1957 = 1588 + 369 
1789    1789 = 1117 + 653 + 19  1789    1789 = 1117 + 653 + 19 
1707 1707  1707  1707  1707  1707 
- 1588  1588  1588  1588  1588 
          
1117 1117  1117 
1136 = 1117 + 19 
1117/1136 1117  1117 
1136 = 1117 + 19 
1062 1062  1062  1062  1062  1062 
          
956 956  956  956  956  956 
          
653 653  653 
672 = 653 + 19 
- 653 
+ BioShuttle  
653 
672 = 653 + 19 
+ BioShuttle  
 369  369    369  369 
 19  19    19  19 Int. J. Med. Sci. 2007, 4 
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Attempt of evaluation of the DNA-transfer methods 
using confocal microscopy (CSLM) 
The efficiency of the BioShuttle transport versus 
lipofection efficiency was compared with help of the 
reporter gene EGFP. The green fluorescence signals 
were observed by CLSM in lipofection and BioShuttle 
treated HeLa cells. Untreated cells were used as a 
control (figure 3, row 1).  
Lipid-mediated DNA transfection 
A strong fluorescence signal was found in few 
HeLa-cells transfected by lipofection while most cells 
showed a diffuse signal. It was conspicuous that the 
fluorescence was located close to the cellular 
membrane. The Differential Interference Contrast 
(DIC) exposures revealed morphologic changes of the 
cells, like membrane-blebbing characteristics of 
apoptosis (figure 3, row 2). 
BioShuttle-mediated DNA transfer 
The fluorescence signals of cells treated with the 
BioShuttle-method were completely different from the 
fluorescence signals of the cells transfected with the 
lipofection-procedure. There was a clear fluorescence 
signal in nearly all the cells, with a cytoplasmic signal 
consistently higher compared to the cell nucleus. The 
range in the fluorescence intensities is homogeneous 
(figure 3, row 3), in contrast to the cells treated with the 
lipofection method. We would like to emphasize, that 
barely visible morphologic changes of the cell 
membranes were observed in the cells transfected with 
the BioShuttle carrier. The fluorescence staining of 
these cells was very homogenous however some 
speckles were detected in the nuclear periphery. The 
transfer efficiency however seems to be very high, 
(nearly 100%) as opposed to the cells treated with 
lipofection. 
 
Figure 3.  Comparison of cells transfected with LipofectAmin or treated with BioShuttle and control cells. The upper row 
shows the CLSM Images of the untreated HeLa control cells. A distinct fluorescence signal is not detectable. The middle row 
exhibits the partial high fluorescence intensity of the LipofectAmin® transfected cells whereas the predominant part of the cells a 
low fluorescence signal located near the cellular membrane (right). The DIC-exposure (left) shows apoptotic features like 
Membrane blebbing. The lower row exemplifies the fluorescence signals in HeLa cells after BioShuttle 
phNIS-IRES-EGFP-transport. In all HeLa cells a nearly homogeneous fluorescence signal could be observed as revealed by 




Quantification of the DNA transfer by iodide-125 
uptake 
The quantitative estimation of the DNA-transfer 
rate into the cell is the basis for a precise measurement 
of the efficiency. The human Sodium iodide 
transporter (phNIS) allows the estimation of the 
cellular iodide uptake after transcription and 
translation in the cells and localization on the cell 
surface. The graph exhibits iodide intensity related to 
1000 cells.  
In our experiments we applied the iodide-125 
uptake-test in a time course of 72 hours. The intensities 
of the radioactivity of iodide-125 correlated to the gene 
transfer rate of the phNIS. The T/2 half-life of 
iodide-125 was taken in account (figure 4). Generally 
we treated cells with LipofectAmin® and 
Clamp-PNA-BioShuttle in parallel dishes. The 
LipofectAmin® transfected sodium symporter 
phNIS-IRES-EGFP adsorbs a higher amount of 
radioactivity 24 hours after DNA-transfer. The signals 
were 4 times higher as in the control (36 × 103, versus 9 
× 103 counts) 1.5-fold higher as the intensity of the cells 
treated with the two different transfected 
Clamp-PNA-BioShuttle sodium symporters (ORI1 22 × 
103 and ORI2 18 × 103  counts). 48 hours after 
lipid-mediated transfection the intensity of the 
radioactivity has increased 11-fold compared to the 
control (45 × 103, versus 4 × 103 counts), whereas the 
intensities of the Clamp-PNA-BioShuttle treated cells 
decreased (ORI1 9 × 103 and ORI2 5 × 103 counts). 72 
hours after LipofectAmin transfection, the radioactive 
intensities were threefold higher as in the control (8 × 
103, versus 3 × 103 counts) and close to the same level as 
in the BioShuttle treated cells (ORI1 4 × 103 and ORI2 7 
× 103 counts) (figure 4). To exclude the cell specific 
uptake of the HeLa cells the results were confirmed 
with rat AT1-cells (data not shown) In parallel the 
EGFP was used for quantitation of the DNA-transfer 
into cells. 
 
Figure  4   Time course of iodide uptake mediated by transfection and transport. In cells treated with two different 
Clamp-PNA-BioShuttle transporters harbouring ORI 1 and ORI 2 phNIS-IRES-EGFP the iodide uptake was measured for a time 
period of 72 hours. The BioShuttle transport was compared with the LipofectAmin® and with the untreated control cells.     
Control   LipofectAmin   ORI 1  ORI 2  
 
Estimation of the cell mortality 
Because many of the cells died, especially after 
treatment with transfection methods, we had to take 
the mortality into consideration. The assessment of the 
progress of mortality and fluorescence intensity needs 
a specific experimental design over 72 hours with 
identical treatment. Cell mortality was quantified by 
flow cytometry, which detects membrane-damaged 
cells stained with propidium iodide (figure 5). The 
relative fraction of propidium iodide stained cells was 
estimated.  
After 24 hours in the untreated control cells (Co) 
the ratio of dead cells remains constant at 5%. The 
LipofectAmin® treated cells (lip) showed a rate of 
17%, which increased to nearly 40% at 48 hours and 
decreased to 15% at 72 hours.  
The rates of mortality of the cells treated with the 
Clamp-PNA-BioShuttle phNIS-IRES-EGFP showed 
similar values like the corresponding controls 24 hours 
after treatment and ranged between 7% and 5 % 
depending on the BioShuttle Clamp-Shuttle-variant. 
The two variants of the Clamp-PNA-BioShuttle 
phNIS-IRES-EGFP show constant cell mortalities: the 
ORI1 variant treated cells exhibit 7%, 5%, and 5% 
mortality, and the ORI2 variant 5%, 6%, and 8% 




Figure 5  Measurement of the cellular mortality after plasmid transfer with transport or transfection.  The  different 
mortality dependent on the transfer method is demonstrated over a three days time period; the mortality of the transported, 
transfected and control was compared. A propidium iodide staining was used as indication for dead cells after transfer of the plasmid. 
The ordinate reveals dead cells [%], the abscissa shows the days after transfer.  
Control   Sham Control  LipofectAmin   ORI 1  ORI 2  
Evaluation of the transcription efficiency - 
quantification 
The accurate evaluation of the transcription after 
Clamp-PNA-BioShuttle phNIS-IRES-EGFP transfer 
demands new techniques. The CLSM is not only a tool 
for demonstration of subcellular localizations, but also 
permits a determination of gene expression by 
integration of frequencies of the different fluorescence 
intensities.  
Based on a standard-area of 0.0531 mm × 0.0531 
mm the distribution of the fluorescence signal 
intensities in HeLa cells after DNA transfer can be 
evaluated using the CLSM resulting in a graphical 
presentation. The abscissas in the picture represent the 
brightness of the fluorescence intensities, the ordinates 
their corresponding absolute frequencies (pixel).  
Fluorescence Brightness Distribution 
Due to the extreme difference of the fluorescence 
intensities in the lipofection treated cells, an estimation 
of intensities is difficult. For this reason we had to 
develop the following method: an appropriate 
standard-area serving as a basis for the calculation of 
frequency and intensity of the signals. In the untreated 
control (figure 6 a) the mean intensity of brightness 
constitutes 638 LI (light illuminance). The sum of the 
number of the frequencies between the intensities of 
fluorescence (2000 and 4080) amounts an area of 8.81 × 
105. 
The Clamp-PNA-BioShuttle phNIS-IRES-EGFP 
treated HeLa cells possessed a medial brightness of 
1102 LI. In the histogram of the BioShuttle treated cells, 
the sum of the number of the frequencies between the 
fluorescence intensities (2000 and 4080) amounts an 
area of 22.17 × 105 (figure 6b). Most of the fluorescence 
signals (maximum frequency) in both samples were 
detected at mean intensities between 288 and 1999, 
which were not considered for the semi-quantitative 
estimation. 
Statistical analysis 
The plot (figure 7) exemplifies the distribution of 
the light intensity. The cells transfected with the 
Clamp-PNA-BioShuttle phNIS-IRES-EGFP (2) 
showed a stronger total fluorescence signal, compared 
to the control (no interception point) (1). The 
comparison of the lines of the LipofectAmin-treated 
cells  (3) with the Clamp-PNA-BioShuttle 
phNIS-IRES-EGFP (2) and the control (1)  revealed 
two interception points at the light intensities 2300 and 
3360. Between these two points the frequency of the 
light intensity in the lipofection treated cells (3) was 
lower than the corresponding frequency in the 
Clamp-PNA-BioShuttle phNIS-IRES-EGFP treated 
cells (2) and higher as in the control cells (1). Above the 
interception point at 3360 light intensities the 
lipofected cells (3) showed a higher frequency than the 
Clamp-PNA-BioShuttle phNIS-IRES-EGFP cells (2). 
The plot also shows that the observed values in a 
logarithmic scale are very close to the calculated 
regression lines [the correlation is -0.9985, -0.9972 and 
-0.9997, respectively, Clamp-PNA-BioShuttle 
phNIS-IRES-EGFP (2) and untreated control (1)]. The 
intercepts  b of the equation y=eax+b are quite similar 
(10.462 and 10.485), whereas the slopes of the two lines 
are different, a = -0.0012 for untreated control, a = 
-0.0009 for lipofection (3) and a = -0.0016 for 
Clamp-PNA-BioShuttle phNIS-IRES-EGFP; the test 
for equal slopes vs. unequal slopes gave a p-value < 







Figure 6. a) Quantification of the DNA transfer and expression with the EGFP reporter gene via CLSM. The histogram (left 
part) represents the distribution of the brightness of the fluorescence in untreated HeLa control cells. The corresponding 
standard-area (0.0531 mm × mm) (right part of the figure) demonstrates a diffuse weak fluorescence, - the correlation of frequency 
and intensity is shown in the histogram which exhibits the relevant fluorescence intensities between 2000 and 4080. The low 
intensity signals are not used for calculation (0-1999). The integral of the green area correlates to the fluorescence intensity of the 
standard-area as described above. b) The histogram (left part) represents the distribution of the brightness of the fluorescence in 
HeLa cells treated with Clamp-PNA-BioShuttle phNIS-IRES-EGFP. The corresponding standard-area (0.0531 mm × mm) (right 
part of the figure) exhibits clear fluorescence signals in all cells, - the correlation of frequency and intensity is shown in the histogram 




Figure 7 Distribution of light intensities.  The graph exhibits both the light intensities of untreated control cells (1) as well as the 
light intensities of Clamp-PNA-BioShuttle phNIS-IRES-EGFP (2) and LipofectAmin (3) treated HeLa cells in comparison. The 
ordinate represents the frequency (log. scale). The abscissa shows the relevant light intensities between 2000 and 4080. 
 
4.  Discussion 
We coupled the BioShuttle carrier with the 
phNIS-IRES-EGFP  plasmid by hybridization to a 
duplex-complementary peptide nucleic acid 
(PNA)-sequences [11] connected via a cysteine spacer 
under clamp-formation for the cell-transfer. To 
improve the final rate-limiting step of nuclear import 
we conjugated the BioShuttle carrier harboring the 
nuclear localization signal (NLS) containing the SV40 
sequence [12]. For annealing and transfer of the 
plasmid the pUC ORI (origin of replication) (figures 1 
and 2) served as hybridization site located outside of 
the coding region. Before the active transport of the 
DNA into the cell nucleus, the peptide being 
responsible for the transport across the cell membrane 
is cleaved off at the cystin-disulfide-brigdes [13]. For 
the nuclear targeting the BioShuttle carrier uses cell 
immanent mechanisms like the importin-based 
transport into the cell nucleus which uses the ran-GDP 
mechanism and proves to be fast and efficient [14]. The 
stability of the PNA/DNA hybridization products 
under physiological conditions is documented [15]. 
Here PNA is suitable as a sequence-specific clutch for 
gene transport and therefore serves as an integral part 
of the BioShuttle delivery platform [13].  
Description of the hybridization 
Since reporter genes are helpful tools, we have 
built a peptide vehicle with a PNA clamp to carry our 
reporter vector. Both components had to be annealed 
for transduction. As a target site for the hybridization 
with the BioShuttle we selected the non coding DNA 
sequence of the ORI region of the plasmid and 
analyzed the transport vehicle by gel electrophoresis 
after annealing. The enzymatic digest should lead to a 
653 bp DNA fragment which harbors the hybridization 
site (figure 1; table 1). The expected fragment was 
detected in the control but not in the hybridized probe. 
The small size of the fragment with 653 bp and the 
hybridized PNA result in a low and hardly detectable 
signal in the agarose gel. The location of the fragment 
with the hybridized PNA however could not be 
detected. The molecular weight of the BioShuttle 
transporter is about 50 000 Daltons, which is believed 
to influence the shift behavior in the agarose gel. 
Further parameters, like electrical charge of the 
PNA/DNA-molecules affecting the shift in mobility 
and possibly ethidium bromide staining, remain to be 
explored. The observed alterations of the shift 
fragment were not completely understood and have to 
be investigated in further experiments. 
Despite the existing intricateness, there are 
several explanations for a DNA/PNA mobility shift 
anomaly in the agarose gel: 
NMR-spectroscopy data [16] and x-ray 
crystallography suggest structural changes of the DNA 
[17]. Due to the fact that sites for restriction enzymes 
further away (5-10 bp from the PNA binding target) 
are not affected by the binding to this target, inhibition 
of the enzymatic cleavage could be excluded [18]. It 
remains unclear to which extent the reduced binding 
of the ethidium bromide (gel staining) to the DNA is 
associated with the PNA-DNA binding in this 
fragment. The formation of PNA / DNA hybrids could 
lead to a type of helix termed the P-form, a natural 
conformation for helices with a PNA backbone [19, 20]. 
The interaction of ethidium bromide with this 
conformation is still unclear. Possibly the change of the 
ethidium bromide /DNA/PNA complex could result 
in a low signal which is not sufficient for detection and 
could influence the interpretation of the DNA 
fragments. 
Mechanisms of the DNA-transfer into cytoplasm 
and nucleus 
With the CLSM it is possible to assign the 
EGFP-fluorescence signals of the reporter gene to their 
subcellular localization, e.g. cytoplasm or cell nucleus Int. J. Med. Sci. 2007, 4 
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after the DNA transfer with the 
Clamp-PNA-BioShuttle phNIS-IRES-EGFP (figure 3; 
row 3), whereas in most of the lipofection treated HeLa 
cells an increased fluorescence signal located near the 
cell membrane could be found. Only a few cells exhibit 
a strong fluorescence signal over the whole cell (figure 
3; row 2). 
The mechanism of the lipid-mediated transfection 
requires endocytosis [21]. The efficiency of the 
lipofection is limited because much of the transfected 
DNA is retained in endosomes, escapes to the 
cytoplasm and enters the nucleus at low rates. 
Additionally the unprotected DNA in the cytoplasm 
could be degraded by resident cytosolic DNases [22].  
In contrast, the mechanism of the 
BioShuttle-mediated gene transfer remains unclear. At 
present the peptide-based transport across the cell 
membrane by formation of inverted micelles finds 
increasing favor in the scientific discussion. Recent 
hints suggest that electrical charge influences the 
transport across the cellular membrane [23].  
Quantitative estimation of gene transfer 
The bi-cistronic vector of phNIS-IRES-EGFP  is 
characterized by the collective transcription of two 
genes located in tandem. They are connected by the 
IRES-sequence, which serves as a second initiation 
point for the ribosomal translation for two separate 
proteins [8]. The correlated simultaneous expression of 
the proteins EGFP and hNIS operates as measuring 
method for the estimation of hNIS by determination of 
the cellular uptake of iodide-125. By using the 
sensitivity of this dual reporter imaging method it 
could be estimated, that cells transfected with 
LipofectAmin® possess a higher radioactive intensity 
compared to the cells which were treated with 
Clamp-PNA-BioShuttle. After 24 hours of the DNA 
transfer the iodide-125 signals were 4 times higher 
than in the control, 1.5-fold higher than the intensity of 
the cells treated with the Clamp-PNA-BioShuttle 
phNIS-IRES-EGFP. Only 48 hours after transfection 
the radioactive intensity is increased 11-fold compared 
to the control, whereas the intensities of the 
Clamp-PNA-BioShuttle  phNIS-IRES-EGFP  treated 
cells remain unchanged. 72 hours after transfection, 
the radioactive intensities were threefold higher 
compared to the control and on the same level as the 
BioShuttle phNIS-IRES-EGFP treated cells (figure 4). 
These results suggest that two well-known 
mechanisms, the sodium iodide symporter (hNIS) and 
the EGFP both could realize the simultaneous 
expression. It should be noted that the gene transfer 
itself is not the only basis for the following gene 
expression. 
Quantitative estimation of gene expression  
The use of physical and biomathematical 
knowledge contributes to a solution for a 
quantification of gene expression after transfer of 
phNIS-IRES-EGFP. Previous EGFP experiments with 
the BioShuttle-mediated gene transfer showed that the 
microscopic epifluorescence method was not suitable 
for an examination of the transfection. The accurate 
evaluation of the efficiency of the transcription after 
the Clamp-PNA-BioShuttle-mediated 
phNIS-IRES-EGFP gene transfer demands new 
techniques like computer-aided microscopy. We could 
demonstrate that the BioShuttle transferred plasmid 
resulted in a homogeneous gene expression profile in 
contrast to the cells transfected with LipofectAmin 
(figures 6a and 6b). When this is calculated and 
graphically represented, it permits an objective 
comparison of the fluorescence intensity and shows a 
gene expression of about 3-fold.  
The quantitative detection of the expression of 
therapeutic or reporter genes is difficult. Additionally, 
the different amounts of uptake of genetic material 
into the target cells and the subsequent different gene 
expression include a reliable quantification. As 
showed in figure (figure 7), the comparison of the lines 
generated by the equations of the numeric values of 
light intensities and their corresponding frequencies 
could account for quantification of the intracellular 
gene expression rate after gene transfer. The 
biostatistical method used here [24] is able to recognize 
the cellular distribution of the different gene 
expression. Further, the method allows the direct 
comparison of the efficacy of different gene transfer 
procedures like the Clamp-PNA-BioShuttle 
phNIS-IRES-EGFP (2) and the lipofection (3). This 
measurement procedure seems not to be restricted to 
the quantitative estimation of gene expression only, 
but every accurate determination of fluorescence 
intensities is feasible.   
Future aspects 
New developments of gene delivery systems 
need new strategies for monitoring the gene transfer 
efficiency and the controlled gene expression in the 
target tissue. Monitoring improvements in transfection 
via confocal laser scanning microscopy (CLSM) and its 
mathematical evaluation represents a promising 
solution. An incontrovertible fact is that a universal 
gene delivery system was not identified yet, but the 
further optimization of these transport vehicles could 
result in having a unique application. The dream of the 
pharmacological science would suddenly become the 
dream of the functional genomics. In this context the 
BioShuttle can be considered as a “smuggler” for 
genetic material into cells. Furthermore, the 
BioShuttle-targeting system could offer a successful 
step in the cell type-specific delivery of molecules for 
intervention by RNAi, aptamers and ribozymes etc. 
However gene therapeutical approaches still have a 
long route to go and require the efforts of investigators 
both in basic and clinical sciences.  
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